Projects per year
Fingerprint
Dive into the research topics where Cancer Institute of New Jersey (CINJ), Breast Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Projects
- 2 Finished
-
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
Qureshi, S., Chan, N., George, M., Ganesan, S., Toppmeyer, D. & Omene, C., Feb 2022, In: Biomarker Insights. 17Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
OlympiA Clinical Trial Steering Committee and Investigators, Dec 1 2022, In: Annals of Oncology. 33, 12, p. 1250-1268 19 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Understanding Cancer Genetic Risk Assessment Intentions in a Tailored Risk Communication Intervention Randomized Controlled Trial
LeCompte, C. G., McDougall, J., Walters, S. T., Toppmeyer, D., Boyce, T. W., Lu, S., Stroup, A., Paddock, L., Grumet, S., Lin, Y., Ani, J., Heidt, E. & Kinney, A. Y., Jul 1 2022, In: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 31, 7, p. 1513-1514 2 p.Research output: Contribution to journal › Article › peer-review